Company Presentation • 30 Jul 2026 20:00
Q2 2026
Company Presentation • 06 May 2026 20:00
Q1 2026
Company Presentation • 19 Feb 2026 21:00
Q4 2025
Company Presentation • 01 May 2025 20:00
Q1 2025
Company Presentation • 26 Feb 2025 21:00
𝛼SK or SearchENTITY
Madrigal Pharmaceuticals Inc (MDGL US)
Madrigal Pharmaceuticals Inc (MDGL US)
17
Analysis
Health Care • United States
Madrigal Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company develops novel and small-molecule drugs addressing cardiovascular and metabolic diseases. Madrigal Pharmaceuticals offers its services in the United States.
morex